Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1624 1626
This examiner grants 84% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18263772 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITORS | Non-Final OA | LG CHEM, LTD. |
| 18287646 | THERAPY FOR ALCOHOL-RELATED LIVER DISEASE | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18701027 | IMPROVED SELECTIVE JAK2 INHIBITORS AND METHODS OF USE | Non-Final OA | Yale University |
| 18275287 | CULLIN-RING E3 UBIQUITIN LIGASE 4 INHIBITOR COMPOUNDS AND METHODS OF THEIR USE | Non-Final OA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| 18518816 | AGENT FOR PREVENTING OR AMELIORATING PRURITUS | Non-Final OA | KAO CORPORATION |
| 18230236 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MOTION SICKNESS AND EMESIS | Non-Final OA | Repurposed Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy